Sms Pharmaceuticals Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sms Pharmaceuticals Limited with three other
companies in this sector in India:
Albert David Limited
sales of 3.22 billion Indian Rupees [US$47.49 million]
Shilpa Medicare Limited
(7.19 billion Indian Rupees [US$106.03 million]
of which 88%
was Bulk Drugs), and
Ttk Healthcare Limited
(5.19 billion Indian Rupees [US$76.48 million]
of which 53%
Sms Pharmaceuticals Limited reported sales of 6.03 billion Indian Rupees (US$88.91 million)
March of 2016.
increase of 4.1%
versus 2015, when the company's sales were 5.79 billion Indian Rupees.
This was the fourth straight year of sales growth at Sms Pharmaceuticals Limited.